Next Article in Journal
Design, Synthesis and Molecular Modeling Study of Conjugates of ADP and Morpholino Nucleosides as A Novel Class of Inhibitors of PARP-1, PARP-2 and PARP-3
Next Article in Special Issue
Claudins in the Renal Collecting Duct
Previous Article in Journal
Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support
Previous Article in Special Issue
Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy
 
 
Review
Peer-Review Record

Tight Junctions of the Outer Blood Retina Barrier

Int. J. Mol. Sci. 2020, 21(1), 211; https://doi.org/10.3390/ijms21010211
by Aisling Naylor, Alan Hopkins, Natalie Hudson and Matthew Campbell *
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2020, 21(1), 211; https://doi.org/10.3390/ijms21010211
Submission received: 21 November 2019 / Revised: 18 December 2019 / Accepted: 19 December 2019 / Published: 27 December 2019
(This article belongs to the Special Issue The Tight Junction and Its Proteins: More Than Just a Barrier)

Round 1

Reviewer 1 Report

Tight junctions of the outer blood retinal barrier

Aisling Naylor, Alan Hopkins, Natalie Hudson and Matthew Campbell

The authors entitled their review “Tight junctions of the outer blood retinal barrier”, and they organized this review in three parts, (i) the RPE, (ii) tight junctions, and (iii) pathology, where they describe how the disruption of the oBRB contributes to the pathogenesis of different ocular pathologies.

 

In the first part, they describe the function of the RPE and in this context they shortly mention the TJ as barrier between the sub-retinal space and the choriocapillaris.

 

The second part is a review about the TJ,and especially about TJ proteins. The only link to the RPE in this part is claudin-19 and mutations in this claudin in many ocular

abnormalities, including macular colobomata.

Line 175: Claudin-19 is expressed and enriched in the RPE, where it is by far the predominant claudin and the only claudin that is RPE specific [27]….

Claudin-19 is also expressed in the kidney, it is not RPE specific.

The claudin-19 mutation should be described under pathologies.

Furthermore, there are other claudins and TJ proteins detected in the RPE and should be mentioned in this review.

 

In the last part, the authors describe of different ocular pathologies, namely DR, and diabetic macular oedema (DMO), AMD, CSCR, Sorsby’s fundal dystrophy and RP. In this part, they mention a depletion of occludin in DR and an upregulation of ZO-1 in an animal model of autosomal recessive RP, in some of the other pathologies, they mention an involvement of the oBRB without providing any detailed information.

 

In summary, this review contains little information about TJs of the outer blood retinal barrier, it provides some information about the function of the RPE, about TJs and about different ocular pathologies with involvement of the RPE. There are different studies on TJ proteins in the RPE, on animal models with disturbed BRB, and a good review should include these information.

 

Minor points:

Line 59: The RPE is composed of a single layer of cells joined laterally towards their apices by TJs between adjacent cell walls.

RPE cells don’t have cell walls, please write cell membranes.

 

Line 99: …of the Na+/K+-ATPase – Please write Na+/K+-ATPase

 

Line 110: ………..recycled to PRs [2, 12] This……………….

Please insert a dot after [2, 12]

 

Line 122: These proteins include occludin, claudin family members and JAMs.

Please mention not only occluding, but the TJ-associated MARVEL proteins (TAMP), comprising occludin, tricellulin, and MarvelD3.

Line 306: The TJs between the RPE form the OBRB – please write oBRB

 

 

 

 

Author Response

Line 175: Claudin-19 is expressed and enriched in the RPE, where it is by far the predominant claudin and the only claudin that is RPE specific [27]….

Claudin-19 is also expressed in the kidney, it is not RPE specific.

The claudin-19 mutation should be described under pathologies.

This has been amended.

Furthermore, there are other claudins and TJ proteins detected in the RPE and should be mentioned in this review.

 This has been amended.

 

In the last part, the authors describe of different ocular pathologies, namely DR, and diabetic macular oedema (DMO), AMD, CSCR, Sorsby’s fundal dystrophy and RP. In this part, they mention a depletion of occludin in DR and an upregulation of ZO-1 in an animal model of autosomal recessive RP, in some of the other pathologies, they mention an involvement of the oBRB without providing any detailed information.

 We have elaborated on this section in more detail.

 

Minor points:

Line 59: The RPE is composed of a single layer of cells joined laterally towards their apices by TJs between adjacent cell walls.

RPE cells don’t have cell walls, please write cell membranes.

Amended.

 

Line 99: …of the Na+/K+-ATPase – Please write Na+/K+-ATPase

 Amended.

 

Line 110: ………..recycled to PRs [2, 12] This……………….

Please insert a dot after [2, 12]

Amended.

 

 Line 122: These proteins include occludin, claudin family members and JAMs.

Please mention not only occluding, but the TJ-associated MARVEL proteins (TAMP), comprising occludin, tricellulin, and MarvelD3.

Amended.

Line 306: The TJs between the RPE form the OBRB – please write oBRB

Amended.

Reviewer 2 Report

The manuscript by Aisling Naylor et al. is a concise review on the tight junctions of the outer retinal barrier. The review is well written and contains relevant information about the specific aspects of retinal pigment epithelial cells including pathological conditions.

Inclusion of a figure depicting the local cellular arrangement and a table summarizing the specific aspects of the outer retinal barrier tight junctions would greatly improve the understandability of the manuscript.

 

Author Response

Figures now included.

Round 2

Reviewer 1 Report

In the revised version, the authors addressed most of the reviewers suggestions.

 

Minor points:

Line 256: ….occurred occurred         Please delete occurred

Line 257: ….. Zo-1                    Please write ZO-1

Line 258: ….[51].It                  Please insert a space

Line 290: …. changing dry into wet   Please write ….dry into wet AMD

Author Response

Amended

Back to TopTop